JPWO2021001306A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021001306A5 JPWO2021001306A5 JP2021577642A JP2021577642A JPWO2021001306A5 JP WO2021001306 A5 JPWO2021001306 A5 JP WO2021001306A5 JP 2021577642 A JP2021577642 A JP 2021577642A JP 2021577642 A JP2021577642 A JP 2021577642A JP WO2021001306 A5 JPWO2021001306 A5 JP WO2021001306A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- acid
- nootropic
- lmtx
- nootropic composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1909454.9 | 2019-07-01 | ||
| GBGB1909454.9A GB201909454D0 (en) | 2019-07-01 | 2019-07-01 | Enhancers |
| PCT/EP2020/068229 WO2021001306A1 (en) | 2019-07-01 | 2020-06-29 | Methylthioninium as enhancers of the cognitive function |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022539185A JP2022539185A (ja) | 2022-09-07 |
| JPWO2021001306A5 true JPWO2021001306A5 (https=) | 2023-07-07 |
| JP2022539185A5 JP2022539185A5 (https=) | 2023-07-07 |
| JP7686581B2 JP7686581B2 (ja) | 2025-06-02 |
Family
ID=67539959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021577642A Active JP7686581B2 (ja) | 2019-07-01 | 2020-06-29 | 認知機能の向上薬としてのメチルチオニニウム |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220330594A1 (https=) |
| EP (1) | EP3989977A1 (https=) |
| JP (1) | JP7686581B2 (https=) |
| KR (1) | KR20220028045A (https=) |
| CN (1) | CN114096254A (https=) |
| AU (1) | AU2020298737B2 (https=) |
| BR (1) | BR112021025330A2 (https=) |
| CA (1) | CA3143417A1 (https=) |
| GB (1) | GB201909454D0 (https=) |
| IL (1) | IL289341A (https=) |
| MX (1) | MX2021015289A (https=) |
| WO (1) | WO2021001306A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3121169T3 (da) | 2006-07-11 | 2022-02-28 | Wista Lab Ltd | Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser |
| DK3826639T3 (da) | 2018-07-26 | 2024-09-23 | Wista Lab Ltd | Optimeret dosering af diaminophenothiaziner i populationer |
| KR102856378B1 (ko) | 2022-09-30 | 2025-09-08 | 주식회사 젬백스앤카엘 | 4r 타우병증의 치료 또는 예방용 펩티드 |
| AU2024231880A1 (en) | 2023-03-03 | 2025-09-11 | Taurx Therapeutics Management Ltd. | Diaminophenothiazine for the treatment of microvascular brain disease disease |
| KR20240176447A (ko) | 2023-06-15 | 2024-12-24 | 주식회사 젬백스앤카엘 | 신규 펩티드 및 이의 용도 |
| KR102800994B1 (ko) | 2023-11-06 | 2025-04-29 | 주식회사 엘지에너지솔루션 | 무음극 코팅층 및 이를 포함하는 전고체 전지 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| EP2013191B3 (en) | 2006-03-29 | 2019-02-27 | Wista Laboratories Ltd. | 3,7-diamino-10h-phenothiazine salts and their use |
| CN101820884B (zh) * | 2007-06-19 | 2013-08-28 | 维斯塔实验室有限公司 | 用于治疗轻度认知缺损的吩噻嗪化合物 |
| CA3027974C (en) | 2007-10-03 | 2022-03-15 | Wista Laboratories Ltd. | Therapeutic use of diaminophenothiazines |
| EA025033B1 (ru) | 2011-02-11 | 2016-11-30 | Уиста Лэборэтэриз Лтд. | Диаминиевые соли фенотиазина и их применение |
| EP2705841A1 (en) | 2012-09-05 | 2014-03-12 | Pharnext | Combinations of nootropic agents for treating cognitive dysfunctions |
| KR102592614B1 (ko) * | 2016-07-25 | 2023-10-24 | 위스타 레보레이토리스 리미티드 | 디아미노페노티아진 (diaminophenothiazines)의 투여 및 투여량 (dosage) |
| GB201614834D0 (en) * | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
-
2019
- 2019-07-01 GB GBGB1909454.9A patent/GB201909454D0/en not_active Ceased
-
2020
- 2020-06-29 EP EP20735367.3A patent/EP3989977A1/en active Pending
- 2020-06-29 WO PCT/EP2020/068229 patent/WO2021001306A1/en not_active Ceased
- 2020-06-29 AU AU2020298737A patent/AU2020298737B2/en active Active
- 2020-06-29 US US17/620,956 patent/US20220330594A1/en active Pending
- 2020-06-29 JP JP2021577642A patent/JP7686581B2/ja active Active
- 2020-06-29 CA CA3143417A patent/CA3143417A1/en active Pending
- 2020-06-29 CN CN202080048926.1A patent/CN114096254A/zh active Pending
- 2020-06-29 BR BR112021025330A patent/BR112021025330A2/pt unknown
- 2020-06-29 KR KR1020227003214A patent/KR20220028045A/ko not_active Ceased
- 2020-06-29 MX MX2021015289A patent/MX2021015289A/es unknown
-
2021
- 2021-12-23 IL IL289341A patent/IL289341A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| de Boer et al. | Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study | |
| AU2020203101B9 (en) | Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability | |
| US11464767B2 (en) | Prodrugs of phenolic TRPV1 agonists in combination with local anesthetics and vasoconstrictors for improved local anesthesia | |
| JP2020519661A5 (https=) | ||
| US11786496B2 (en) | Composition and methods for treating intestinal hyperpermeability | |
| RU2006109467A (ru) | Способы лечения рака с использованием ингибиторов hdac | |
| JPWO2004017996A1 (ja) | 関節軟骨細胞外マトリクス分解阻害剤 | |
| CN107835695B (zh) | 用于治疗自闭症的组合物和方法 | |
| KR20070041561A (ko) | 오심 및 구토의 치료에서의 치환된2-티오-3,5-디시아노-4-페닐-6-아미노피리딘의 용도 | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2021532187A (ja) | 非アルコール性脂肪肝炎の予防または治療用の薬学組成物 | |
| JPWO2021001306A5 (https=) | ||
| PT1562577E (pt) | Acetil-l-carnitina para a prevenção e/ou tratamento de neuropatias periféricas induzidas pela talidomida | |
| CN103002893B (zh) | 神经障碍性疼痛的治疗药或预防药 | |
| JP2018525447A5 (https=) | ||
| WO1992003135A1 (en) | Pharmaceutical compositions containing 5-difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl] benzimidazole and an anti-helicobacter agent for the treatment of gastrointestinal disorders | |
| CN115038447A (zh) | 用于治疗癌症的组合疗法 | |
| JP2011502112A (ja) | 抗ガン治療の副作用を治療するための新規組成物 | |
| WO2023066330A1 (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| HUP0203790A2 (hu) | (6-Metoxi-2-naftil)-ecetsav prodrugokat tartalmazó gyógyszerkészítmények alkalmazása gyulladás kezelésére | |
| WO2022255790A1 (ko) | 폐섬유화증의 예방 또는 치료용 약학 제제 | |
| US12502371B2 (en) | Drug for treating and preventing dementia | |
| US7608625B2 (en) | Method for treating bruxism and bruxism-related diseases | |
| ES2483940T3 (es) | Un nuevo régimen de dosificación para compuestos moduladores del canal iónico para el tratamiento de la fibrilación auricular aguda en un ser humano | |
| WO2024225821A1 (ko) | 폐섬유화 예방 또는 치료를 위한 펙시다티닙 및 닌테다닙의 병용 요법 |